RecruitingNot ApplicableNCT06479343

Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations: a Prospective, Multi-center, Randomized, Parallel Positive Controlled, Non-inferiority Trial

Sponsor

Ton-Bridge Medical Tech. Co., Ltd

Enrollment

170 participants

Start Date

Jun 27, 2024

Study Type

INTERVENTIONAL

Conditions

Intracranial Arteriovenous Malformations

Summary

The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Liquid Embolic System (Tonbridge) and a medical device called Onyx Liquid Embolic System (Medtronic) for people with intracranial arteriovenous malformations. The study is currently recruiting participants at 14 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELiquid Embolic System (Tonbridge)

Endovascular treatment with Liquid Embolic System (Tonbridge).

DEVICEOnyx Liquid Embolic System (Medtronic)

Endovascular treatment with Onyx Liquid Embolic System (Medtronic).

Locations(14)

Nanfang Hospital Southern Medical University

Guangzhou, Guangdong, China

Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, China

Henan Provincial People's Hospital

Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

General Hospital of Eastern Theater Command

Nanjing, Jiangsu, China

The First Hospital of Jilin University

Changchun, Jilin, China

General Hospital of Northern Theater Command

Shenyang, Liaoning, China

Qilu Hospital of Shandong University

Jinan, Shandong, China

Xuanwu hospital Capital Medical University

Beijing, China

Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital

Chengdu, China

Guangdong Provincial People's Hospital

Guangzhou, China

Anhui Provincial Hospital

Hefei, China

Jining No.1 People's Hospital

Jining, China

Tongji Hospital Tongji Medical College of HUST

Wuhan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06479343

Related Trials

PHIL® Embolic System Pediatric IDE

NCT037310001 location

Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)

NCT043281811 location